Spirulina
Dried Arthrospira cyanobacterial biomass sold as a food supplement. Reviews describe diverse nutritional and experimental findings, but the human evidence is heterogeneous and does not establish one transferable pharmacokinetic exposure profile.
Pharmacokinetic model
A route-level PK model for spirulina is being prepared from published data. Dosing references, studies, and documented interactions are below; the app catalog is updated as models are validated.
Key facts
- Category
- Supplement
- Suggested cadence
- once daily
Research behind this entry
-
The antioxidant, immunomodulatory, and anti-inflammatory activities of Spirulina: an overview
Narrative overview surveyed cell, animal, and human literature concerning multiple Spirulina constituents and proposed immune or oxidative mechanisms. It is not a quantitative clinical efficacy synthesis and does not…
-
Spirulina Microalgae and Brain Health: A Scoping Review of Experimental and Clinical Evidence
Scoping review mapped a literature dominated by experimental models and heterogeneous interventions. Clinical evidence was limited, preventing confident conclusions about neurological benefits or a standardized…
-
A randomized, double blind, placebo controlled study of spirulina supplementation on indices of mental and physical fatigue in men.
This citation reports a human clinical study involving Spirulina. It does not by itself establish a qualified dose, safety profile, efficacy claim, or pharmacokinetic route for this record.
3 published studies referenced in the app, each with a plain-language summary.